文献速递主动脉外科先天性心脏病外科

先天性主动脉瓣上狭窄的长期外科结局:系统评价、荟萃分析与微观模拟研究

Long-term surgical outcomes of congenital supravalvular aortic stenosis: a systematic review, meta-analysis and microsimulation study.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

该系统评价纳入23篇文献共1472例先天性主动脉瓣上狭窄手术患者,汇总早期死亡率为4.2%,晚期死亡率为每患者年0.61%。微观模拟显示修复后30年预期寿命为匹配一般人群的90.7%,30年再干预风险为31.3%。作者推荐终身监测心血管系统,尤其关注残余狭窄和冠状动脉梗阻。

要点

  • 汇总早期死亡率为4.2%(95%CI 3.2-5.5%),晚期死亡率为每患者年0.61%(95%CI 0.45-0.83)。
  • 微观模拟估计修复后30年预期寿命为匹配一般人群的90.7%(95%可信区间 90.0-91.6%)。
  • 30年再干预风险为31.3%(95%可信区间 29.6-33.4%),其中27.2%因修复功能障碍。

核心结论

  • 先天性主动脉瓣上狭窄外科修复后30年生存率低于匹配一般人群,终身再干预风险可观。
  • 作者推荐终身监测心血管系统,尤其关注残余狭窄和冠状动脉梗阻。

研究设计与样本

  • 系统评价纳入报告儿童或成人主动脉瓣上狭窄修复后长期临床结局(>2年)且患者数>20的观察性研究。
  • 共纳入23篇文献,合计1472例患者(13125患者年;汇总平均随访9.0(6.2)年;中位随访6.3年)。
  • 汇总早期风险、晚期事件率和时间-事件数据输入微观模拟模型估计30年结局,并与年龄、性别和来源匹配的一般人群比较预期寿命。

主要发现

  • 汇总手术修复平均年龄为4.7(5.8)岁,最常用手术技术为单补片修复(43.6%)。
  • 汇总早期死亡率为4.2%(95%CI 3.2-5.5%),晚期死亡率为每患者年0.61%(95%CI 0.45-0.83)。
  • 微观模拟估计30年内心肌梗死风险为8.1%(95%可信区间 7.3-9.9%),再干预风险为31.3%(95%可信区间 29.6-33.4%),其中27.2%(95%可信区间 25.8-29.1)因修复功能障碍。

关键数值与推荐

  • 纳入标准:观察性研究,报告儿童或成人主动脉瓣上狭窄修复后长期临床结局(>2年),患者数>20。
  • 汇总平均随访9.0(6.2)年,中位随访6.3年。
  • 汇总平均手术修复年龄4.7(5.8)岁,单补片修复占43.6%。
  • 早期死亡率4.2%(95%CI 3.2-5.5%),晚期死亡率每患者年0.61%(95%CI 0.45-0.83)。
  • 30年预期寿命为匹配一般人群的90.7%(95%可信区间 90.0-91.6%),30年心肌梗死风险8.1%(95%可信区间 7.3-9.9%),再干预风险31.3%(95%可信区间 29.6-33.4%)。

临床怎么用

  • 作者推荐终身监测心血管系统,尤其关注残余狭窄和冠状动脉梗阻。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Congenital supravalvular aortic stenosis (SVAS) is a rare form of congenital outflow tract obstruction and long-term outcomes are scarcely reported. This study aims to provide an overview of outcomes after surgical repair for congenital SVAS. METHODS: A systematic review of published literature was conducted, including observational studies reporting long-term clinical outcome (>2 years) after SVAS repair in children or adults considering >20 patients. Early risks, late event rates and time-to-event data were pooled and entered into a microsimulation model to estimate 30-year outcomes. Life expectancy was compared to the age-, sex- and origin-matched general population. RESULTS: Twenty-three publications were included, encompassing a total of 1472 patients (13 125 patient-years; pooled mean follow-up: 9.0 (6.2) years; median follow-up: 6.3 years). Pooled mean age at surgical repair was 4.7 (5.8) years and the most commonly used surgical technique was the single-patch repair (43.6%). Pooled early mortality was 4.2% (95% confidence interval: 3.2-5.5%) and late mortality was 0.61% (95% CI: 0.45-0.83) per patient-year. Based on microsimulation, over a 30-year time horizon, it was estimated that an average patient with SVAS repair (mean age: 4.7 years) had an observed life expectancy that was 90.7% (95% credible interval: 90.0-91.6%) of expected life expectancy in the matched general population. The microsimulation-based 30-year risk of myocardial infarction was 8.1% (95% credible interval: 7.3-9.9%) and reintervention 31.3% (95% credible interval: 29.6-33.4%), of which 27.2% (95% credible interval: 25.8-29.1) due to repair dysfunction. CONCLUSIONS: After surgical repair for SVAS, 30-year survival is lower than the matched-general-population survival and the lifetime risk of reintervention is considerable. Therefore, lifelong monitoring of the cardiovascular system and in particular residual stenosis and coronary obstruction is recommended.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Meccanici F, Notenboom ML, Meijssen J, et al. Long-term surgical outcomes of congenital supravalvular aortic stenosis: a systematic review, meta-analysis and microsimulation study. Eur J Cardiothorac Surg. 2024. PMID: 37889257. doi:10.1093/ejcts/ezad360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。